-
Add to Cart The item has been added1100100200604AE31E AE31E Main Body
Price: $3,693.30List Price: $4,103.66AE31E AE31E Main Body -
Add to Cart The item has been addedA02115-40Anti-Eculizumab Antibody (4F6), mAb, Mouse,40ug
Price: $332.02List Price: $368.91Eculizumab with trade name Soliris, is an FDA-approved drug to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. Eculizumab is a recombinant humanized monoclonal antibody against -
Add to Cart The item has been addedA02116-40Anti-Eculizumab Antibody(13F5), mAb, Mouse,40ug
Price: $332.02List Price: $368.91Eculizumab with trade name Soliris, is an FDA-approved drug to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. Eculizumab is a recombinant humanized monoclonal antibody against -
Add to Cart The item has been addedS962317-250MGECHUJIN-
Price: $188.79List Price: $209.76ECHUJIN- -
Add to Cart The item has been addedAb170870-100μgEculizumab (anti-Complement C5) (C007B-327696)
Price: $172.90List Price: $192.12Eculizumab (anti-Complement C5) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab (anti-Complement C5) inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement -
Add to Cart The item has been addedAb170870-10mgEculizumab (anti-Complement C5) (C007B-327697)
Price: $2,662.48List Price: $2,958.31Eculizumab (anti-Complement C5) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab (anti-Complement C5) inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement -
Add to Cart The item has been addedAb170870-1mgEculizumab (anti-Complement C5) (C007B-327698)
Price: $581.23List Price: $645.81Eculizumab (anti-Complement C5) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab (anti-Complement C5) inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement -
Add to Cart The item has been addedAb170870-5mgEculizumab (anti-Complement C5) (C007B-327699)
Price: $1,748.80List Price: $1,943.11Eculizumab (anti-Complement C5) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab (anti-Complement C5) inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement -
Add to Cart The item has been addedAb177847-100μgEnibarcimab (anti-Adrenomedullin) (C007B-328653)
Price: $190.21List Price: $211.35Enibarcimab (anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research. -
Add to Cart The item has been addedAb177847-10mgEnibarcimab (anti-Adrenomedullin) (C007B-328654)
Price: $2,618.06List Price: $2,908.96Enibarcimab (anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research. -
Add to Cart The item has been addedAb177847-1mgEnibarcimab (anti-Adrenomedullin) (C007B-328655)
Price: $632.31List Price: $702.57Enibarcimab (anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research. -
Add to Cart The item has been addedAb177847-5mgEnibarcimab (anti-Adrenomedullin) (C007B-328656)
Price: $1,702.58List Price: $1,891.76Enibarcimab (anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research.
